MC
CMD

Miles Capital’s Cantel Medical Corporation CMD Stock Holding History

Miles Capital’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,135
Closed -$295K – 210
2016
Q1 		$295K Buy
+4,135
New +$260K 0.2% 118
2013
Q3 		– Sell
-13,166
Closed -$297K – 141
2013
Q2 		$297K Buy
+13,166
New +$285K 0.14% 111

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Miles Capital's CMD Position: Q2 2016 in Review

Miles Capital sold out of Cantel Medical Corporation (CMD) in Q2 2016, closing a stake of 4,135 shares — an estimated $295K sold.

Miles Capital first reported a position in CMD in Q2 2013 and held it in 2 quarters. The position peaked at $297K in Q2 2013. 231 funds tracked by Wall St. Rank hold CMD as of Q2 2016.

  • Miles Capital reported no remaining Cantel Medical Corporation position as of Q2 2016 after selling out during the quarter.
  • Miles Capital sold 4,135 Cantel Medical Corporation shares in Q2 2016, an estimated $295K.
  • Miles Capital first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 2 quarters.
  • Miles Capital's Cantel Medical Corporation position peaked at $297K in Q2 2013.
  • 231 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2016.

Based on Miles Capital's 13F filing for Q2 2016, filed 11 Aug 2016.